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Priapism is defined as an unwanted, prolonged, and painful erection which is unrelated to sexual stimulation.
Some case studies suggest that priapism is an adverse effect of antipsychotic medications. In our case study a
30 year-old Iranian male with schizophrenia was experiencing recurrent priapism associated with quetiapine
use. There are three interesting facts about this case: Firstly, the patient suffered priapism after even low dose
consumption of quetiapine. Secondly, this case had experienced priapism with risperidone, olanzapine, and even
clozapine in the past, suggesting a possible pharmacodynamic interaction of antipsychotics and inner biological
traits in this particular case. Thirdly, priapism induced by low dose quetiapine was resolved after cigarette smoking.
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The etiology of priapism may be idiopathic, drug-
induced, or related to some medical problems like sickle
cell disease or leukemia [1]. Priapism has been noted as
an adverse effect of both first- and second-generation
anti psychotic medications [2]. Peripheral alpha-1 adren-
ergic blockade has been considered as the main cause of
priapism [3]. Trazodone with its alpha-1 antagonistic
properties, has been reported to induce priapism [4].
Antipsychotics are accounted for 15-26% of priapism
cases that are induced by medications [5]. Previous case
reports of priapism associated with quetiapine were
those with a total daily dose of 600mg or greater [4,6-9].
One case involved a single overdose of 675mg [8]. Pres-
ently, we report a case of priapism associated with 25mg
use of quetiapine [10].
Case Presentation
A 30 year old single unemployed man was presented to
our out-patient psychiatry clinic because of a recurrence
of the psychotic episode. The patient did not have any
comorbidity with medical diseases or substance abuse
disorders in the past. Recurrence of the psychotic epi-
sode was due to the self-discontinuation of quetiapine* Correspondence: mmppg@yahoo.com
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reproduction in any medium, provided the orsecondary to recurrent priapism. He was diagnosed with
paranoid schizophrenia since 10 years ago. His main
symptoms included delusions of control, persecutory
delusion, and auditory hallucination. His symptoms were
relatively controlled. He had several recurrences and all
of them were associated with drug discontinuation due
to the patient's lack of compliance. He did not have
any major stressors before recurrences. He was under
treatment of first- and second-generation antipsychotics.
He developed drug-induced Parkinsonism several times
which was resolved with dose-adjustment and anti cho-
linergic therapy. The patient experienced priapism sec-
ondary to use of some antipsychotic medications like
risperidone, olanzapine, clozapine and finally quetiapine.
The diagnosis of priapism was confirmed by a urologic
consult. All medical causes of priapism were ruled-out
by a thorough urological history and physical examin-
ation. To prevent priapism, we substituted the combin-
ation therapy of lithium and sodium-valproate for
control of psychotic symptoms. After six months he
again experienced psychotic symptoms. Then, we started
a low-dose quetiapine (25mg per day, gradually increased
to 100mg per day). After 2months of this regimen, he
experienced a 6- hour-long painful priapism. It was
resolved with diazepam use without any surgical inter-
vention. Despite reducing the quetiapine dose to 25mg
per day, he experienced priapism every 4–5days. Aston-
ishingly, he did not experience priapism with accidentall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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not have a history of substance abuse disorder. He acci-
dentally and adaptively smoked cigarette to get rid of pri-
apism. After a two-week challenge test of smoking
cessation, he re-experienced priapism again. After all the
challenges and even though smoking is considered a
maladaptive behavior to get rid of the side effects, the
patient decided to keep on smoking while consuming
quetiapine. He has not been complaining of priapism
since then. Patient signed a consent form for publication
of this report.
Discussion
In a few cases quetiapine has been described as the
cause of priapism [1-5], which may be due to its inter-
mediate affinity for alpha-1 adrenoceptors as compared
with other atypical antipsychotic medications [11]. Not-
ably, some cases have even suggested using quetiapine
for patients who are at risk for developing priapism [9].
An interesting fact about this case is the relationship be-
tween smoking cessation and recurrence of priapism.
It is well-known that cigarette smoking induces cyto-
chrome P450 1A2 (CYP1A2) and as a result it may
decreases the serum level of some drugs like olanzapine
and clozapine that are CYP1A2 substrates [12]. How-
ever, since quetiapine is not a known CYP1A2 substrate,
the effect of cigarette smoking on this drug may be due
to an unknown interaction. One of the limitations of
our study was that we did not check the serum level of
quetiapine before and after smoking. Therefore, we do
not have any valid evidence that shows the changes
of quetiapine concentration with cigarette smoking. Ano-
ther limitation of this study is the lack of an objectified
scoring system to show the effect size of this correlation.
Thus, the presented report leads to a correlation between
cigarette smoking and disappearing of priapism in this
case rather than causality between the variables. Certain
aspects of this case merit further comment and compa-
rison to other reported cases. In the present case, the
patient received daily doses of quetiapine far lower than
600mg that was given in other studies [5,8,13-16]. Fur-
thermore, this patient had experienced priapism with
different types of antipsychotics. Therefore, the authors
suggest that this patient may have a biological and/or
genetic tendency to develop drug-induced priapism.
Further studies on the connection between biological
tendencies and drug-induced priapism are recommended.
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